Open AccessCRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping
Author(s) -
Thomas Naert,
Dieter Tulkens,
Tom Van Nieuwenhuysen,
Joanna Przybył,
Suzan Demuynck,
Matt van de Rijn,
Mushriq AlJazrawe,
Benjamin A. Alman,
Paul Coucke,
Kim De Leeneer,
Christian Vanhove,
Savvas N. Savvides,
David Creytens,
Kris Vleminckx
Publication year - 2021
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2115116118
Subject(s) - crispr , druggability , wnt signaling pathway , computational biology , biology , cancer research , carcinogenesis , genome editing , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom